Edesa Biotech, Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Edesa Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Edesa Biotech, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.93M, a 6.38% increase year-over-year.
  • Edesa Biotech, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.38M, a 13.5% increase year-over-year.
  • Edesa Biotech, Inc. annual Operating Income (Loss) for 2023 was -$9.22M, a 49.8% increase from 2022.
  • Edesa Biotech, Inc. annual Operating Income (Loss) for 2022 was -$18.4M, a 22.4% increase from 2021.
  • Edesa Biotech, Inc. annual Operating Income (Loss) for 2021 was -$23.7M, a 270% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$9.22M +$9.15M +49.8% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-15
2022 -$18.4M +$5.31M +22.4% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-15
2021 -$23.7M -$17.3M -270% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-16
2020 -$6.4M Oct 1, 2019 Sep 30, 2020 10-K 2021-12-28
2018 -$1.62M +$3.61M +69% Jan 1, 2018 Dec 31, 2018 10-KT 2019-12-12
2017 -$5.22M -$316K -6.44% Oct 1, 2016 Sep 30, 2017 10-K 2018-11-30
2016 -$4.91M -$570K -13.1% Oct 1, 2015 Sep 30, 2016 10-K 2017-12-01
2015 -$4.34M +$1.38M +24.1% Oct 1, 2014 Sep 30, 2015 10-K 2017-12-01
2014 -$5.72M Sep 1, 2013 Aug 31, 2014 10-K 2016-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.